## ğŸ”¬ ê°œë…ì  Research Framework: mycobacterial pathogenesis

*ìë™ ìƒì„±ëœ ë¬¸ì œ-í•´ê²° ê³„í†µë„*

### ğŸ”‘ í•µì‹¬ ê°œë… (Key Concepts)

1. Mycobacterium tuberculosis
2. Tuberculosis
3. Immunology
4. Microbiology
5. Immune system
6. Pathology
7. Disease
8. Sarcoidosis
9. Mycobacterium
10. Pathogenesis

---

### 1. í•µì‹¬ ë¬¸ì œ (Core Problems)

#### 1.1 Disease

**ê´€ë ¨ ë…¼ë¬¸** (3 papers):

- "General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobac..." (2020, 221 citations)
- "General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobac..." (2020, 221 citations)
- "Etiologies of Sarcoidosis..." (2015, 152 citations)

---

#### 2.2 Pathology

**ê´€ë ¨ ë…¼ë¬¸** (4 papers):

- "Histopathologic review of granulomatous inflammation..." (2017, 323 citations)
- "Protein Kinase G Induces an Immune Response in Cows Exposed to<i>Mycobacterium a..." (2018, 232 citations)
- "PE_PGRS proteins of<i>Mycobacterium tuberculosis</i>: A specialized molecular ta..." (2020, 102 citations)
- *...and 1 more papers*

---

#### 3.3 Tuberculosis

**ê´€ë ¨ ë…¼ë¬¸** (3 papers):

- "Macrophage form, function, and phenotype in mycobacterial infection: lessons fro..." (2016, 121 citations)
- "Neutrophils express pro- and anti-inflammatory cytokines in granulomas from Myco..." (2019, 109 citations)
- "Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis..." (2017, 115 citations)

---

### 2. ì ‘ê·¼ ë°©ì‹ (Approaches)

#### 1.1 Pathology

**ê´€ë ¨ ë…¼ë¬¸** (6 papers):

- "Histopathologic review of granulomatous inflammation..." (2017, 323 citations)
- "Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis..." (2016, 120 citations)
- "Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis..." (2017, 115 citations)
- *...and 3 more papers*

**ì„¸ì…˜ ë‚´ ì—°ì‚¬**: Speaker A - Neutrophils

---

#### 2.2 Pathology

**ê´€ë ¨ ë…¼ë¬¸** (6 papers):

- "Etiologies of Sarcoidosis..." (2015, 152 citations)
- "Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, ..." (2017, 120 citations)
- "Sensing of <i><scp>M</scp>ycobacterium tuberculosis</i> and consequences to both..." (2015, 113 citations)
- *...and 3 more papers*

---

#### 3.3 Tuberculosis

**ê´€ë ¨ ë…¼ë¬¸** (6 papers):

- "Paradoxical reactions and immune reconstitution inflammatory syndrome in tubercu..." (2015, 109 citations)
- "Anti-inflammatory effects of 2nd generation antipsychotics in patients with schi..." (2023, 53 citations)
- "Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tubercu..." (2023, 31 citations)
- *...and 3 more papers*

---

### 3. í•œê³„ì  & ëŒíŒŒêµ¬ (Limitations & Breakthroughs)

*No í•œê³„ identified in analysis.*

### 4. ë¯¸ë˜ ë°©í–¥ (Future Directions)

#### 1.1 Pathology

**ê´€ë ¨ ë…¼ë¬¸** (14 papers):

- "Cell-based wound dressing: Bilayered PCL/gelatin nanofibers-alginate/collagen hy..." (2023, 45 citations)
- "Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: rece..." (2023, 37 citations)
- "Functional genetic variation in pe/ppe genes contributes to diversity in Mycobac..." (2023, 30 citations)
- *...and 11 more papers*

---

#### 2.2 Tuberculosis

**ê´€ë ¨ ë…¼ë¬¸** (13 papers):

- "How Neutrophils Shape the Immune Response: Reassessing Their Multifaceted Role i..." (2023, 45 citations)
- "M.Â tuberculosis relies on trace oxygen to maintain energy homeostasis and surviv..." (2023, 35 citations)
- "Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aerug..." (2023, 29 citations)
- *...and 10 more papers*

---

#### 3.3 Immunology

**ê´€ë ¨ ë…¼ë¬¸** (13 papers):

- "Sarcoidosis: Epidemiology and clinical insights..." (2023, 108 citations)
- "NETosis Drives Blood Pressure Elevation and Vascular Dysfunction in Hypertension..." (2024, 30 citations)
- "Clinical characteristics of patients with non-tuberculous mycobacterial pulmonar..." (2023, 28 citations)
- *...and 10 more papers*

**ì„¸ì…˜ ë‚´ ì—°ì‚¬**: Speaker C - Drug Targets

---

---

*Generated by Conceptual Framework Builder v1.0*
